agn 1

AGN 192836 is a potent and selective α2 adrenergic agonist (EC50s: 8.7, 41 and 6.6 nM for α2A, α2B and α2C receptor).

AGN 194078 is a selective RARα agonist (Kd: 3 nM; EC50: 112 nM).

AGN 196996是一种高效且具有选择性的RARα抑制剂（Ki：2 nM）。AGN 196996对RARβ和RARγ的亲和性极低，Ki 分别为1087 nM 和8523 nM。

AGN 194310 (VTP-194310) is retinioic acid receptors (RARs) pan-antagonist. The Kd values of 3 nM, 2 nM, 5 nM for RARα, RARβ, RARγ, respectively[1][2].

AGN 191701 is an agonist of the Retinoid X receptor.

Agn 190727 is a retonoic acid receptor that can induce retinoid-induced hypertriglyceridemia.

AGN 191864 is a biochemical.

AGN 191976 is a novel thromboxane A2-mimetic.

AGN 192171 is a biochemical.

AGN 192240 is a biochemical.

AGN 192870 是一种有效的维甲酸受体（RAR） 拮抗剂，，对 RARα、RARβ 和 RARγ 亲和力很高。AGN 192870 可用于研究细胞生长停滞，分化和凋亡。

AGN 193109 是一种类视黄醇类似物，是一种有效的特异性 RAR 拮抗剂，可抑制 RARα、RARβ和 RARγ的活性，Kd 值分别为 2 nM、2 nM 和 3 nM。

AGN 193109 is a potent antagonist of retinoic acid receptors (RARs; Kd= 2, 2, and 3 nM for RARα, β, and γ, respectively), exhibiting selectivity for RARs over retinoid X receptors (RXRs; Kd= >10,000 nM for human RXRα, β, and γ receptors). This compound effectively reverses cellular morphology changes and growth suppression induced by RAR agonists such as all-trans-RA, 13-cis-RA, and 9-cis-RA in ECE16-1 human endometrial ectocervical epithelial cells, particularly when used at a 10-fold molar excess. Furthermore, AGN 193109 downregulates the expression of cytokeratin K5-8, 13, 14, 16, 17, and 19 genes, indicating inhibition of retinoid action, specifically when co-administered with TTNPB but not as a standalone treatment. In vivo studies demonstrate teratogenic effects, including cleft palate, frontonasal dysplasia, and eye malformations in mouse fetuses following a single oral dose of 1 mg kg.

Rasagiline Mesylate (AGN1135) 是一种高效的，不可逆的选择性线粒体单胺氧化酶 (MAO) 抑制剂，抑制大鼠脑 MAO B 和 MAO A 的IC50分别为 4.43 nM 和 412 nM。

Tazarotene (Zorac) 是一种选择性视黄酸受体激动剂，用于研究寻常痤疮和斑块状银屑病。

AGN-191129, also known as Prostaglandin F2α alcohol methyl ether (PGF2α-OMe), is an analog of PGF2α in which the C-1 carboxyl group has been replaced by an O-methyl ether. The compound is reported to retain ocular hypotensive properties, but the receptors

AGN-190383 is a phospholipase inhibitor with topical anti-inflammatory activity.

TTNPB (Ro 13-7410,AGN-191183) 是一种RAR 激动剂。在使用人RARs 进行竞争性结合实验中，作用于RARα，RARβ和RARγ，IC50分别为 5.1 nM，4.5 nM 和 9.3 nM。

AGN 195183 is a potent and selective agonist of RARα(Kd=3 nM) with improved binding selectivity relative to AGN 193836; no activity on RARβ/γ. IC50 value: 3 nM (Kd); 200 nM (EC80, RAR Trans.) Target: RARα agonist Compound 4(AGN-195183) inhibited the growt

AGN194204 (IRX4204) is inactive against RAR and is an orally active and selective RXR agonist with Kd values 0.4 nM, 3.6 nM and 3.8 nM and EC50s of 0.2 nM, 0.8 nM and 0.08 nM for RXRα, RXRβ and RXRγ, respectively. AGN194204 has anti-inflammatory and antic

AGN-199659 is a novel tyrosine kinase inhibitor. It also blocks choroidal neovascularization.

AGN192093 is a bioactive chemical.

KSK213 is a potent inhibitor of Chlamydia trachomatis Infectivity (EC50 = 60 nM). KSK213 potently inhibited multiple serovars of C. trachomatis while not affecting the growth of key species from the commensal flora or host cell viability at 25 μM.

AGN-191659 is a Retinoid X Receptor (RXR) pan-agonist. RXR pan-agonists have been shown to modulate endothelial cell proliferation.